Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v11-EN | Version v3-EN | |
---|---|---|
Language | English | English |
Date Updated | 2020-07-09 | 2020-04-13 |
Drug Identification Number | 02483890 | 02483890 |
Brand name | AZITHROMYCIN FOR INJECTION USP | AZITHROMYCIN FOR INJECTION USP |
Common or Proper name | AZITHROMYCIN FOR INJECTION USP | AZITHROMYCIN FOR INJECTION USP |
Company Name | STERIMAX INC | STERIMAX INC |
Ingredients | AZITHROMYCIN | AZITHROMYCIN |
Strength(s) | 500MG | 500MG |
Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
Packaging size | 10 VIALS | 10 VIALS |
ATC code | J01FA | J01FA |
ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
Anticipated start date | ||
Actual start date | 2020-03-30 | 2020-03-30 |
Estimated end date | Unknown | |
Actual end date | 2020-07-08 | |
Shortage status | Resolved | Actual shortage |
Tier 3 Status | No | No |
Company comments | Product is available at McKesson at 100% allocation. Covering Pfizer for Ontario and Alberta. | |
Health Canada comments |